Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Year-over-year research & development expense growth
Percentile
P7
Near historical low
vs 3Y Ago
-2.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -22.30% |
| 2023 | 67.15% |
| 2022 | 32.15% |
| 2021 | 8.84% |
| 2020 | -2.81% |
| 2019 | -3.19% |
| 2018 | -3.42% |
| 2017 | 1.14% |
| 2016 | 31.47% |
| 2015 | 8.52% |